OTCMKTS:MJTV MJ Biotech (MJTV) Stock Price, News & Analysis $0.0004 0.00 (0.00%) As of 09/9/2021 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About MJ Biotech Stock (OTCMKTS:MJTV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MJ Biotech alerts:Sign Up Key Stats Today's Range$0.0004▼$0.000450-Day Range N/A52-Week Range$0.0001▼$0.0159VolumeN/AAverage Volume6.17 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Michael James Enterprises, Inc. engages in the production and distribution of Hemp (CBD) infused Teas and Herb products. The company was founded on December 30, 2010 and is headquartered in Boynton Beach, FL. Read More Receive MJTV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MJ Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address MJTV Stock News HeadlinesHere's How Michael Jordan Became the Richest Athlete of All TimeApril 9, 2023 | thestreet.comNavigating Themes, Valuations, and Opportunities in BiotechnologyFebruary 24, 2023 | nasdaq.comA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for. | Investors Alley (Ad)Jefferies' Michael Yee on Biogen as FDA could be on the verge of approving Alzheimer's drugJanuary 6, 2023 | msn.comJefferies' Michael Yee still likes Amgen in the biotech sectorDecember 28, 2022 | msn.comMissed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and HoldOctober 13, 2022 | fool.comChi-Biotech Launches Free-To-Use Next-Gen FANSe-Based Sequencing Analysis Solution on Amazon's Cloud PlatformSeptember 22, 2022 | yahoo.comBiotech stocks have been overlooked for the past year and a half, says Jefferies' Michael YeeAugust 3, 2022 | msn.comSee More Headlines MJTV Stock Analysis - Frequently Asked Questions How have MJTV shares performed this year? MJ Biotech's stock was trading at $0.0004 at the beginning of the year. Since then, MJTV stock has increased by 0.0% and is now trading at $0.0004. How do I buy shares of MJ Biotech? Shares of MJTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MJ Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that MJ Biotech investors own include Fernhill (FERN), Puget Technologies (PUGE), Amazonas Florestal (AZFL), Ayr Strategies (AYRSF), Anavex Life Sciences (AVXL), AVVAA World Health Care Products (AVVH) and APT Systems (APTY). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryComputer Software Current SymbolOTCMKTS:MJTV CIKN/A Webwww.mjbiotech.us Phone(561) 563-3830FaxN/AEmployees2Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:MJTV) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MJ Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MJ Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access